Recurrent Ovarian Cancer and Anxiety

Links shared publicly online about this topic

Cancer recurrence fears 'overlooked'

physorg.com — “(PhysOrg.com) -- The anxiety of cancer returning is often overlooked by both patients and medics, according to leading experts in the disease.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on February 24, 2009 at 9:28 pm By:

First Recurrent Gene Fusion Identified In Ovarian Cancer

medicalnewstoday.com — “Researchers studying ovarian cancer have discovered that, in a substantial fraction of ovarian tumors, a gene closely related to the estrogen receptor is broken and fused to an adjacent gene by aView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 22, 2011 at 7:05 am By:

mnt_ovariancanc MNT Ovarian Cancer Health News

First Recurrent Gene Fusion Identified In Ovarian Cancer http://mnt.to/3ZMY #ovariancancer

8 months ago...

Understanding Psychotherapy for Anxiety Disorders | Free Articles About Breast Cancer, Ovarian Cancer, Diabetes, Alternative medicine, Leukemia and Mesothelioma

your-safe-mall.com — “Millions of Americans have an Anxiety Disorder, along with tens of millions who have increased stress and anxiety - but without the panic attacks thatView full resource at your-safe-mall.com

  • View Related
  • Share

Most Recently Shared on July 18, 2010 at 12:06 am By:

docapc DrCiaramicoli PhD, EdD, Doctor, and Psychologist

RT @AnxietyRelief: Understanding Psychotherapy for Anxiety Disorders | Free Articles ... http://bit.ly/9lxCWD

2 years ago...

Ovarian cancer vaccine: Can it prevent recurrence? - MayoClinic.com

mayoclinic.com — “Research continues to evaluate the role of an ovarian cancer vaccine to prevent recurrence.View full resource at mayoclinic.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 2:20 am By:

J_Bohlen Julie Bohlen Health Executive and Active Health Library

Ovarian cancer vaccine: Can it prevent recurrence?: Research continues to evaluate the role of an ovarian cancer... http://t.co/fbwU0zDZ

2 months ago...

Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer

medicalnewstoday.com — “Ovarian cancer is a major health concern for women and the identification of sensitive biomarkers for early detection and/or monitoring of disease recurrence is of high clinical relevance.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 9, 2011 at 9:07 am By:

mnt_ovariancanc MNT Ovarian Cancer Health News

Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer http://t.co/7OgdD8rC #ovariancancer

6 months ago...

Bevacizumab Added to Chemotherapy Provides Meaningful Benefit in Recurrent Ovarian Cancer

onclive.com — “Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in PFS when bevacizumab was added to chemotherapy and continued as maintenance therapy.View full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on July 27, 2011 at 7:45 pm By:

ONClive Editor Oncology

Bevacizumab Added to Chemotherapy Provides Meaningful Benefit in Recurrent Ovarian Cancer http://t.co/gLOIrDB

10 months ago...

Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability - ONA

oncologynurseadvisor.com — “The combination of oxaliplatin and doxorubicin showed promising efficacy in either platinum-sensitive or platinum-resistant recurrent ovarian cancer, as reported by Ilya Pokateav, MD, from the Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, and colleagues at the American Society of Clinical Oncology’s 2011 Annual Meeting.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on June 5, 2011 at 5:23 pm By:

ONAcom OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher

Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability http://goo.gl/fb/ldXlW

12 months ago...

Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - ONA

oncologynurseadvisor.com — “Amgen announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on June 7, 2010 at 8:20 pm By:

Dr. Karlan Discusses AMG 386 in Recurrent Ovarian Cancer

onclive.com — “Beth Y. Karlan MD Discusses AMG 386 in Recurrent Ovarian CancerView full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on May 5, 2011 at 6:51 pm By:

ONClive Editor Oncology

OncLive TV: Dr. Beth Karlan from @CedarsSinai Discusses AMG 386 in Recurrent Ovarian Cancer http://goo.gl/eO2xa

1 year ago...

Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer - MPR

empr.com — “Amgen announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on June 7, 2010 at 8:14 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 2 trial of AMG 386 for treatment of recurrent ovarian cancer: Amgen announced that AMG 386, combin... http://bit.ly/cBbIUj

2 years ago...

Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer : Internal Medicine News

internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice treView full resource at internalmedicinenews.com

  • View Related
  • Share

Most Recently Shared on June 5, 2011 at 11:58 pm By:

MiriamETucker Miriam E. Tucker Patient Expert

RT @IntMedNews: Bevacizumab Halves Progression Risk in Recurrent Ovarian #Cancer http://bit.ly/ipBNsP

12 months ago...

Detecting breast cancer recurrence

physorg.com — “Connie Krabbe understands the fear and foreboding breast cancer survivors feel when visiting their physicians for post-treatment check-ups. Two of her four sisters died of metastatic cancer related to breast cancer, enduring bone, brain and ovarian cancer before succumbing to the disease in their early ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 3:12 pm By:

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer

hindawi.com — “Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian CancerView full resource at hindawi.com

  • View Related
  • Share

Most Recently Shared on August 29, 2011 at 6:40 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer: Thi... http://t.co/C0fygZk

9 months ago...

Husband suffering with anxiety and depression | Ask the Therapist

psychcentral.com — “My husband is a 57yo and has been diagnosed with Major Depressive Disorder and Anxiety. His problem started in April, 2010. He is unable to read and write. HeView full resource at psychcentral.com

  • View Related
  • Share

Most Recently Shared on November 20, 2010 at 10:17 am By:

psychcentral Psych Central Health Site

Ask the Therapist: Husband suffering with anxiety and depression http://bit.ly/bWgFPl

2 years ago...

Oncology Article | ovarian cancer

mdlinx.com — “Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohortView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 10:32 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive su... http://t.co/VTK4Upu #oncology

9 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • FightCancer

    FightCancer

    Cancer news feed, formerly part of a blog. RSS suggestions welcome.

    View Profile

  • mnt_ovariancanc

    MNT Ovarian Cancer

    The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

  • docapc

    DrCiaramicoli

    Clinical psychologist,author and speaker.I focus on helping people shore up their sense of self and contribute to making a better world.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390